<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.5-a.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//ph-ksp.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://ph-ksp.com/corsairs-treprostinil-transdermal-patch-for-pulmonary-arterial-hypertension-pah-moves-closer-to-clinical-development-biospace-november-10-2026/</loc>
  <lastmod>2026-11-11T15:46:17Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Corsair’s treprostinil transdermal patch for pulmonary arterial hypertension (PAH) moves closer to clinical development, Biospace, November 10, 2026</news:title>
   <news:publication_date>2026-11-11T15:46:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/united-therapeutics-corporation-announces-the-u-s-food-and-drug-administration-fda-clearance-to-proceed-with-clinical-trial-for-treprostinil-iloprost-soft-mist-inhaler-smi-in-pulmonary-arterial-h/</loc>
  <lastmod>2026-11-11T14:36:08Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>United Therapeutics Corporation announces the U.S. Food and Drug Administration (FDA) Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost Soft Mist Inhaler (SMI) in pulmonary arterial hypertension (PAH)</news:title>
   <news:publication_date>2026-11-11T14:30:22Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/lung-transplantation-for-severe-pulmonary-arterial-hypertension-pah-how-far-can-we-go-pro-lung-transplantation-journal-of-heart-and-lung-transplantation-open-november-2026/</loc>
  <lastmod>2026-11-11T14:37:28Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Lung transplantation for severe pulmonary arterial hypertension (PAH) - How far can we go? Pro-lung transplantation, Journal of Heart and Lung Transplantation Open, November 2026</news:title>
   <news:publication_date>2026-11-11T14:16:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/inhaled-nanogels-ameliorate-vascular-remodeling-in-pulmonary-arterial-hypertension-via-normalization-of-endothelia-smooth-muscle-cell-crosstalk-bioactive-materials-march-2027-edition/</loc>
  <lastmod>2026-11-11T14:38:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Inhaled nanogels ameliorate vascular remodeling in pulmonary arterial hypertension via normalization of endothelia - smooth muscle cell crosstalk, Bioactive Materials, March 2027 edition</news:title>
   <news:publication_date>2026-11-11T13:49:23Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/the-connection-between-systemic-hypertension-and-pulmonary-hypertension-jama-cardiology-october-30-2026/</loc>
  <lastmod>2026-11-11T15:28:25Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>The connection between Systemic Hypertension and Pulmonary Hypertension, JAMA Cardiology, October 30, 2026</news:title>
   <news:publication_date>2026-11-11T06:09:33Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/the-role-of-treprostinil-inhalation-powder-among-inhaled-formulations-for-pulmonary-arterial-hypertension-the-annals-of-pharmacotherapy-october-30-2026/</loc>
  <lastmod>2026-11-11T14:40:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>The role of Treprostinil Inhalation Powder among inhaled formulations for Pulmonary Arterial Hypertension, The Annals of Pharmacotherapy, October 30, 2026</news:title>
   <news:publication_date>2026-11-11T05:56:13Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/study-uncovers-why-pulmonary-hypertension-patients-report-symptoms-of-cognitive-decline-journal-of-clinical-investigation-november-2-2026/</loc>
  <lastmod>2026-11-11T14:36:13Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Study uncovers why pulmonary hypertension patients report symptoms of cognitive decline, Journal of Clinical Investigation, November 2, 2026</news:title>
   <news:publication_date>2026-11-10T18:24:12Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
